148 related articles for article (PubMed ID: 36920267)
21. PDK-1/AKT pathway as a novel therapeutic target in rhabdomyosarcoma cells using OSU-03012 compound.
Cen L; Hsieh FC; Lin HJ; Chen CS; Qualman SJ; Lin J
Br J Cancer; 2007 Sep; 97(6):785-91. PubMed ID: 17848913
[TBL] [Abstract][Full Text] [Related]
22. Expression of insulin-like growth factor pathway proteins in rhabdomyosarcoma: IGF-2 expression is associated with translocation-negative tumors.
Makawita S; Ho M; Durbin AD; Thorner PS; Malkin D; Somers GR
Pediatr Dev Pathol; 2009; 12(2):127-35. PubMed ID: 18788888
[TBL] [Abstract][Full Text] [Related]
23. The Role of BiP and the IRE1α-XBP1 Axis in Rhabdomyosarcoma Pathology.
Aghaei M; Nasimian A; Rahmati M; Kawalec P; Machaj F; Rosik J; Bhushan B; Bathaie SZ; Azarpira N; Los MJ; Samali A; Perrin D; Gordon JW; Ghavami S
Cancers (Basel); 2021 Sep; 13(19):. PubMed ID: 34638414
[TBL] [Abstract][Full Text] [Related]
24. Alveolar rhabdomyosarcoma has superior response rates to vinorelbine compared to embryonal rhabdomyosarcoma in patients with relapsed/refractory disease: A meta-analysis.
Allen-Rhoades W; Lupo PJ; Scheurer ME; Chi YY; Kuttesch JF; Venkatramani R; Meyer WH; Mascarenhas L
Cancer Med; 2023 May; 12(9):10222-10229. PubMed ID: 37016270
[TBL] [Abstract][Full Text] [Related]
25. Case of pleomorphic rhabdomyosarcoma arising on subcutaneous tissue in an adult patient: Review of the published works of 13 cases arising on cutaneous or subcutaneous tissue.
Watanabe M; Ansai SI; Iwakiri I; Fukumoto T; Murakami M
J Dermatol; 2017 Jan; 44(1):59-63. PubMed ID: 27569112
[TBL] [Abstract][Full Text] [Related]
26. Embryonal and Alveolar Rhabdomyosarcoma in Adults: Real-Life Data From a Tertiary Sarcoma Centre.
Drabbe C; Benson C; Younger E; Zaidi S; Jones RL; Judson I; Chisholm J; Mandeville H; Fisher C; Thway K; Al Muderis O; Messiou C; Strauss D; Husson O; Miah A; Van der Graaf WTA
Clin Oncol (R Coll Radiol); 2020 Jan; 32(1):e27-e35. PubMed ID: 31350181
[TBL] [Abstract][Full Text] [Related]
27. Rhabdomyosarcoma: From Obscurity to Clarity in Diagnosis … But With Ongoing Challenges in Management: The Farber-Landing Lecture of 2020.
Parham DM; Giannikopoulos P
Pediatr Dev Pathol; 2021; 24(2):87-95. PubMed ID: 33439112
[TBL] [Abstract][Full Text] [Related]
28. Analysis of prognostic factors in patients with nonmetastatic rhabdomyosarcoma treated on intergroup rhabdomyosarcoma studies III and IV: the Children's Oncology Group.
Meza JL; Anderson J; Pappo AS; Meyer WH;
J Clin Oncol; 2006 Aug; 24(24):3844-51. PubMed ID: 16921036
[TBL] [Abstract][Full Text] [Related]
29. The World Health Organization Classification of Skeletal Muscle Tumors in Pediatric Rhabdomyosarcoma: A Report From the Children's Oncology Group.
Rudzinski ER; Anderson JR; Hawkins DS; Skapek SX; Parham DM; Teot LA
Arch Pathol Lab Med; 2015 Oct; 139(10):1281-7. PubMed ID: 25989287
[TBL] [Abstract][Full Text] [Related]
30. Soft tissue sarcomas of childhood: the differential diagnostic dilemma of the small blue cell.
Dehner LP
Natl Cancer Inst Monogr; 1981 Apr; (56):43-59. PubMed ID: 6272117
[TBL] [Abstract][Full Text] [Related]
31. Rhabdomyosarcoma.
Skapek SX; Ferrari A; Gupta AA; Lupo PJ; Butler E; Shipley J; Barr FG; Hawkins DS
Nat Rev Dis Primers; 2019 Jan; 5(1):1. PubMed ID: 30617281
[TBL] [Abstract][Full Text] [Related]
32. Detection of PAX3/PAX7-FKHR fusion transcripts in rhabdomyosarcoma and other small round cell tumors by 1-step reverse transcriptase polymerase chain reaction: a novel tool for diagnosis and differentiation.
Yang XL; Zhang SC; Zhang SW; Wang H
Ann Diagn Pathol; 2012 Apr; 16(2):107-11. PubMed ID: 22197543
[TBL] [Abstract][Full Text] [Related]
33. Progress in the diagnosis and treatment of rhabdomyosarcoma and related soft tissue sarcomas.
Ruymann FB; Grovas AC
Cancer Invest; 2000; 18(3):223-41. PubMed ID: 10754991
[TBL] [Abstract][Full Text] [Related]
34. Histology and fusion status in rhabdomyosarcoma.
Rudzinski ER
Am Soc Clin Oncol Educ Book; 2013; ():425-8. PubMed ID: 23714565
[TBL] [Abstract][Full Text] [Related]
35. Molecular classification of rhabdomyosarcoma--genotypic and phenotypic determinants of diagnosis: a report from the Children's Oncology Group.
Davicioni E; Anderson MJ; Finckenstein FG; Lynch JC; Qualman SJ; Shimada H; Schofield DE; Buckley JD; Meyer WH; Sorensen PH; Triche TJ
Am J Pathol; 2009 Feb; 174(2):550-64. PubMed ID: 19147825
[TBL] [Abstract][Full Text] [Related]
36. Childhood rhabdomyosarcoma with anaplastic (pleomorphic) features. A report of the Intergroup Rhabdomyosarcoma Study.
Kodet R; Newton WA; Hamoudi AB; Asmar L; Jacobs DL; Maurer HM
Am J Surg Pathol; 1993 May; 17(5):443-53. PubMed ID: 8470759
[TBL] [Abstract][Full Text] [Related]
37. Diagnosis and Management of Rhabdomyosarcoma in Children and Adolescents: ICMR Consensus Document.
Panda SP; Chinnaswamy G; Vora T; Prasad M; Bansal D; Kapoor G; Radhakrishnan V; Agarwala S; Laskar S; Arora B; Kaur T; Rath GK; Bakhshi S
Indian J Pediatr; 2017 May; 84(5):393-402. PubMed ID: 28378141
[TBL] [Abstract][Full Text] [Related]
38. Potential combination chemotherapy approaches for advanced adult-type soft-tissue sarcoma.
Kopp HG; Patel S; Brücher B; Hartmann JT
Am J Clin Dermatol; 2008; 9(4):207-17. PubMed ID: 18572972
[TBL] [Abstract][Full Text] [Related]
39. [Molecular mechanisms regulating metastasis of cancer cells with special emphasis on rhabdomyosarcoma].
Tarnowski M; Grymuła K; Tkacz M; Czerewaty M; Poniewierska-Baran A; Ratajczak MZ
Postepy Hig Med Dosw (Online); 2014 Mar; 68():258-70. PubMed ID: 24662794
[TBL] [Abstract][Full Text] [Related]
40. DNA ploidy and proliferative activity (S-phase) in childhood soft-tissue sarcomas: their value as prognostic indicators.
Niggli FK; Powell JE; Parkes SE; Ward K; Raafat F; Mann JR; Stevens MC
Br J Cancer; 1994 Jun; 69(6):1106-10. PubMed ID: 8198978
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
